<DOC>
	<DOCNO>NCT02389374</DOCNO>
	<brief_summary>This study assess safety efficacy current national guideline treatment uncomplicated malaria Bangladesh well assess G6PD status among enrolled patient .</brief_summary>
	<brief_title>A Study Assess Safety Current Standard Malaria Treatment Assessment G6PD Status South-east Bangladesh</brief_title>
	<detailed_description>The national guideline treatment uncomplicated malaria Bangladesh currently recommend standard dose artemether-lumefantrine follow single dose primaquine P. falciparum malaria three day course chloroquine follow 14 day primaquine vivax malaria.Currently national treatment guideline include test G6PD deficiency treatment primaquine . In order guarantee safe efficacious treatment patient diagnose uncomplicated malaria Bangladesh , essential monitor effectiveness safety recommend treatment guideline . This trial therefore evaluate local efficacy safety current first line treatment ass G6PD status enrol patient . Patients uncomplicated malaria attend health care center , meet study inclusion criterion enrol , treat site follow 28 day . The follow-up consist fix schedule check-up visit correspond clinical laboratory examination . The study provide efficacy data artemether-lumefantrine chloroquine generate data G6PD status region , provide vital information policy maker regard wider roll primaquine radical cure vivax malaria .</detailed_description>
	<mesh_term>Malaria</mesh_term>
	<mesh_term>Artemether-lumefantrine combination</mesh_term>
	<mesh_term>Artemisinins</mesh_term>
	<mesh_term>Lumefantrine</mesh_term>
	<mesh_term>Artemether</mesh_term>
	<mesh_term>Primaquine</mesh_term>
	<mesh_term>Chloroquine</mesh_term>
	<mesh_term>Chloroquine diphosphate</mesh_term>
	<criteria>Age ≥ 12 month P. vivax P. falciparum monoinfection P.v . / P.f . mixed infection Presence axillary temperature ≥ 37.5°C history fever past 24 hr Ability swallow oral medication . Ability willingness comply study protocol duration study Informed consent/assent patient parent guardian case child . Presence general danger sign child age 5 year sign severe malaria accord definition WHO Presence severe malnutrition Acute anaemia &lt; 8g/dL Regular medication , may interfere antimalarial pharmacokinetics History hypersensitivity reaction contraindication drug ( ) test used alternative treatment ( ) A positive pregnancy test lactating</criteria>
	<gender>All</gender>
	<minimum_age>12 Months</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
</DOC>